Skip to content

Clinical trials

Macular Degeneration trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Latvia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20131
20141
20151
20181
20192
20203
20212
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ophthotech Corporation2
4D Molecular Therapeutics1
Allergan1
Alvotech Swiss AG1
Amgen1
Astellas Pharma Global Development, Inc.1
Bayer1
EyeBiotech Ltd.1
Forsight Vision41
IVERIC bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration17
Wet Macular Degeneration4
Choroidal Neovascularization3
Eye Diseases3
Retinal Degeneration3
Retinal Diseases3
Geographic Atrophy2
Vision Disorders2
Blindness1
Vision, Low1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.